Revolution Medicines, Inc. (RVMD)

Revolution Medicines Revenue

In the year 2023, Revolution Medicines had annual revenue of $11.58M, a decrease of -67.27%. Revenue in the quarter ending December 31, 2023 was $742.00K, a -95.16% decrease year-over-year.

• Revenue (ttm): $11.58M
• Revenue Growth: -67.27%
• P/S Ratio: 530.19
• Revenue / Employee: $30,635
• Employees: 378
• Market Cap: 6.14B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	11.58M	-23.80M	-67.27%
Dec 31, 2022	35.38M	5.99M	20.38%
Dec 31, 2021	29.39M	-13.59M	-31.62%
Dec 31, 2020	42.98M	-7.06M	-14.10%
Dec 31, 2019	50.04M	29.88M	148.16%
Dec 31, 2018	20.17M	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.